Search results
Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend
Simply Wall St. via Yahoo Finance· 1 day agoBased on the last year's worth of payments, Pfizer has a trailing yield of 6.0% on the current stock...
Morgan Stanley Raises Pfizer (NYSE:PFE) Price Target to $29.00
ETF DAILY NEWS· 6 hours agoPfizer (NYSE:PFE – Free Report) had its price target boosted by Morgan Stanley from $28.00 to $29.00 in a research report report published on Thursday, ...
Pfizer (NYSE:PFE) Earns Outperform Rating from BMO Capital Markets
ETF DAILY NEWS· 6 hours agoBMO Capital Markets currently has a $36.00 price target on the biopharmaceutical company’s stock, up from their prior price target of ...
3 No-Brainer Stocks to Buy in May
Motley Fool via Yahoo Finance· 4 hours agoPfizer. The stock is incredibly cheap, it pays a dividend, and it's still one of the safest healthcare investments you can own...growth ...
Pfizer stock gains 7% after earnings beat, company calls dividend 'secure'
Yahoo Finance via AOL· 4 days ago"The dividend is a sacred cow for us. The dividend — it is secure, and we will continue our policy...
These 3 Real Estate Stocks With Over 4% Dividend Yields Are Recommended By Wall Street's Most...
Benzinga· 4 days agoThis analyst has...Properties Realty Trust, Inc. EPRT Dividend Yield: 4.33% Stifel analyst Simon...
Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings - ...
Benzinga· 5 days agoPfizer's Q1 earnings report expects EPS of 49 cents and $13.09 billion in revenues. Stock has...
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
Motley Fool via Yahoo Finance· 1 day agoPfizer Pfizer (NYSE: PFE) isn't getting much attention due to a lack of anti-obesity treatments, but...
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Motley Fool via Yahoo Finance· 1 day agoAnd I think it will be a player in this huge market -- even if it requires buying another company to...
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.
Motley Fool via Yahoo Finance· 3 days agoThe drugmaker's shares have printed fresh 52-week lows consistently over the past two years, putting its stock in serious bargain territory. Speaking to...
